JAMP recalls vitamin D3:Out of Specification
Last updated
Summary
Product
JAMP Vitamin D3
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Vidextra |
DIN 02417685 |
Tablet |
Vitamin D3 Tablet/ Cholecalciferol 10000UI/Tablet |
B011345 |
|
JAMP-Vitamin D |
DIN 02379007 |
Tablet |
Vitamin D3 Tablet/ Cholecalciferol 10000UI/Tablet |
B007557, B011322, B011323, B011324, B011325, B011331, B011333, B011334, B011335, B011336, B011337, B011338, B011339, B011340, B011341, B011342, B011343, B011344, |
|
AG-Vitamin D |
DIN 02498944 |
Tablet |
Vitamin D3 Tablet/ Cholecalciferol 10000UI/Tablet |
B013048 |
Issue
The dissolution for vitamin D3 is out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Wholesalers
Details
Original published date: 2022-06-22
Alert / recall type
Health product recall
Category
Health product - Drugs
Companies
Jamp Pharma Corporation.
1310 rue Nobel,
Boucherville, Québec,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-64300